Le Lézard
Classified in: Health
Subjects: PDT, WOM, DEI

FemiClear Launches Ground-Breaking Product for Bacterial Vaginosis Symptoms in Walgreens Stores Nationwide


AUSTIN, Texas, Nov. 29, 2022 /PRNewswire/ -- FemiClear, known for its ever-growing line of all-natural vaginal health products, announced its newest offering this week: a 2-day remedy for bacterial vaginosis symptoms. 

FemiClear Launches Ground-Breaking Product for Bacterial Vaginosis Symptoms in Walgreens Stores Nationwide

This remedy, which, like all its products, can be purchased over the counter, works quickly and is highly effective. With just a 2-day dose, it is proven to kill 99.9% of the bacteria that can cause bacterial vaginosis* and 91% of users reported their BV symptoms were eliminated**.

According to the Centers for Disease Control, Bacterial Vaginosis is the most common vaginal problem for women between the ages of 15 and 44. It's also uncomfortable, unpleasant, and can lead to long-term health issues if left untreated.  With this offering, women will have the ability to address their symptoms with a quick trip to their local Walgreens store.

Product Highlights:

FemiClear is on a mission to tackle taboo topics in women's health, creating over-the-counter products that are proven effective and made with all-natural ingredients. FemiClear's parent company, OrganiCare, is a women-led business founded in 2016, in Austin, Texas and has quickly become a leader in transforming the natural healthcare products industry, establishing a new benchmark in scientific rigor to prove efficacy in its products. To learn more about FemiClear and its family of products visit www.FemiClear.com.

*An independent accredited lab performed an in vitro (non-human/non-animal) time kill study to measure the amount of Gardnerella Vaginalis that was killed. An overgrowth of Gardnerella Vaginalis, can cause a bacterial vaginosis (BV) infection, but might not be the only cause. Data on file.

**As self-reported in a comprehensive IRB approved study of >100 women. Individual results may vary. Data on file.

SOURCE OrganiCare


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: